Structure

Physi-Chem Properties

Molecular Weight:  334.25
Volume:  361.281
LogP:  4.069
LogD:  3.553
LogS:  -4.252
# Rotatable Bonds:  3
TPSA:  46.53
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.771
Synthetic Accessibility Score:  5.548
Fsp3:  0.952
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.98
MDCK Permeability:  1.6490004782099277e-05
Pgp-inhibitor:  0.971
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.328
30% Bioavailability (F30%):  0.983

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.255
Plasma Protein Binding (PPB):  80.6801986694336%
Volume Distribution (VD):  0.5
Pgp-substrate:  9.159016609191895%

ADMET: Metabolism

CYP1A2-inhibitor:  0.033
CYP1A2-substrate:  0.681
CYP2C19-inhibitor:  0.041
CYP2C19-substrate:  0.874
CYP2C9-inhibitor:  0.116
CYP2C9-substrate:  0.243
CYP2D6-inhibitor:  0.049
CYP2D6-substrate:  0.619
CYP3A4-inhibitor:  0.923
CYP3A4-substrate:  0.316

ADMET: Excretion

Clearance (CL):  12.082
Half-life (T1/2):  0.136

ADMET: Toxicity

hERG Blockers:  0.134
Human Hepatotoxicity (H-HT):  0.491
Drug-inuced Liver Injury (DILI):  0.506
AMES Toxicity:  0.014
Rat Oral Acute Toxicity:  0.021
Maximum Recommended Daily Dose:  0.555
Skin Sensitization:  0.903
Carcinogencity:  0.546
Eye Corrosion:  0.038
Eye Irritation:  0.139
Respiratory Toxicity:  0.94

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC477929

Natural Product ID:  NPC477929
Common Name*:   methyl (1S,4S,5R,9S,10R,14S)-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate
IUPAC Name:   methyl (1S,4S,5R,9S,10R,14S)-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate
Synonyms:  
Standard InCHIKey:  HCXQUFPQHLFUCK-WQDJLJQSSA-N
Standard InCHI:  InChI=1S/C21H34O3/c1-19-8-4-9-20(2,18(23)24-3)16(19)7-10-21-11-14(5-6-17(19)21)15(12-21)13-22/h14-17,22H,4-13H2,1-3H3/t14?,15-,16+,17+,19-,20-,21+/m1/s1
SMILES:  C[C@@]12CCC[C@@]([C@H]1CC[C@]34[C@H]2CCC(C3)[C@H](C4)CO)(C)C(=O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   163068978
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0003782] Kaurane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30031 Siegesbeckia pubescens Species Asteraceae Eukaryota aerial parts n.a. n.a. PMID[19928884]
NPO30031 Siegesbeckia pubescens Species Asteraceae Eukaryota aerial part n.a. n.a. PMID[24997688]
NPO30031 Siegesbeckia pubescens Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT165 Cell Line HeLa Homo sapiens GI50 > 9020 nM PMID[23353738]
NPT114 Cell Line LoVo Homo sapiens GI50 > 9020 nM PMID[23353738]
NPT139 Cell Line HT-29 Homo sapiens GI50 > 9020 nM PMID[23353738]
NPT461 Cell Line PANC-1 Homo sapiens GI50 > 9020 nM PMID[23353738]
NPT111 Cell Line K562 Homo sapiens GI50 > 9020 nM PMID[23353738]
NPT2 Others Unspecified GI50 > 9020 nM PMID[23353738]
NPT2 Others Unspecified GI50 = 7230 nM PMID[23353738]
NPT2 Others Unspecified Inhibition = 90.74 % PMID[24997688]
NPT2 Others Unspecified IC50 = 5.22 ug/ml PMID[24997688]
NPT2 Others Unspecified Inhibition = 27.7 % PMID[24997688]
NPT2 Others Unspecified IC50 > 10 ug/ml PMID[24997688]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC477929 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9846 High Similarity NPC319671
0.9846 High Similarity NPC469941
0.9846 High Similarity NPC252032
0.9846 High Similarity NPC476734
0.9552 High Similarity NPC469940
0.9403 High Similarity NPC477850
0.9385 High Similarity NPC42060
0.9286 High Similarity NPC477933
0.9286 High Similarity NPC477932
0.9275 High Similarity NPC167702
0.9275 High Similarity NPC477930
0.9275 High Similarity NPC280026
0.9254 High Similarity NPC64466
0.9143 High Similarity NPC477934
0.9143 High Similarity NPC212733
0.9091 High Similarity NPC268736
0.9091 High Similarity NPC477931
0.9028 High Similarity NPC476732
0.9028 High Similarity NPC199965
0.9014 High Similarity NPC4209
0.8955 High Similarity NPC130459
0.8955 High Similarity NPC474221
0.8955 High Similarity NPC478180
0.8904 High Similarity NPC80891
0.8904 High Similarity NPC201276
0.8889 High Similarity NPC180199
0.8889 High Similarity NPC477919
0.8889 High Similarity NPC207010
0.8889 High Similarity NPC317913
0.8889 High Similarity NPC298168
0.8889 High Similarity NPC143133
0.8889 High Similarity NPC477918
0.8873 High Similarity NPC472311
0.8841 High Similarity NPC108131
0.8767 High Similarity NPC224802
0.8767 High Similarity NPC171426
0.8767 High Similarity NPC324700
0.8767 High Similarity NPC80089
0.8767 High Similarity NPC34046
0.8767 High Similarity NPC185465
0.8714 High Similarity NPC320549
0.8714 High Similarity NPC151018
0.8714 High Similarity NPC156277
0.8714 High Similarity NPC58057
0.8696 High Similarity NPC196197
0.8696 High Similarity NPC474962
0.8667 High Similarity NPC58631
0.8649 High Similarity NPC320144
0.863 High Similarity NPC474404
0.8592 High Similarity NPC232112
0.8592 High Similarity NPC310766
0.8553 High Similarity NPC61107
0.8553 High Similarity NPC477935
0.8553 High Similarity NPC289486
0.8533 High Similarity NPC472853
0.8533 High Similarity NPC261616
0.8514 High Similarity NPC329117
0.8472 Intermediate Similarity NPC472854
0.8472 Intermediate Similarity NPC254340
0.8451 Intermediate Similarity NPC473267
0.8429 Intermediate Similarity NPC6120
0.8429 Intermediate Similarity NPC327728
0.8429 Intermediate Similarity NPC213178
0.8429 Intermediate Similarity NPC131892
0.8429 Intermediate Similarity NPC324607
0.8429 Intermediate Similarity NPC321732
0.8421 Intermediate Similarity NPC12933
0.8356 Intermediate Similarity NPC174964
0.8356 Intermediate Similarity NPC179858
0.8356 Intermediate Similarity NPC97534
0.8356 Intermediate Similarity NPC195155
0.8356 Intermediate Similarity NPC273366
0.8356 Intermediate Similarity NPC21220
0.8356 Intermediate Similarity NPC27349
0.8356 Intermediate Similarity NPC125767
0.8356 Intermediate Similarity NPC24014
0.8333 Intermediate Similarity NPC473336
0.8333 Intermediate Similarity NPC471044
0.8312 Intermediate Similarity NPC121121
0.8312 Intermediate Similarity NPC30583
0.8312 Intermediate Similarity NPC477936
0.831 Intermediate Similarity NPC476731
0.8308 Intermediate Similarity NPC476735
0.8289 Intermediate Similarity NPC477851
0.8286 Intermediate Similarity NPC473225
0.8243 Intermediate Similarity NPC475742
0.8243 Intermediate Similarity NPC472486
0.8243 Intermediate Similarity NPC246445
0.8243 Intermediate Similarity NPC5767
0.8243 Intermediate Similarity NPC472487
0.8205 Intermediate Similarity NPC259173
0.8205 Intermediate Similarity NPC245866
0.8194 Intermediate Similarity NPC478227
0.8194 Intermediate Similarity NPC89310
0.8194 Intermediate Similarity NPC472309
0.8194 Intermediate Similarity NPC197701
0.8158 Intermediate Similarity NPC472310
0.8143 Intermediate Similarity NPC41542
0.8133 Intermediate Similarity NPC264602
0.8133 Intermediate Similarity NPC221420
0.8133 Intermediate Similarity NPC475031
0.8133 Intermediate Similarity NPC68828
0.8133 Intermediate Similarity NPC66105
0.8133 Intermediate Similarity NPC23884
0.8125 Intermediate Similarity NPC12774
0.8125 Intermediate Similarity NPC92139
0.8101 Intermediate Similarity NPC319909
0.8101 Intermediate Similarity NPC263974
0.8082 Intermediate Similarity NPC330659
0.8082 Intermediate Similarity NPC279241
0.8082 Intermediate Similarity NPC244708
0.8082 Intermediate Similarity NPC161187
0.8077 Intermediate Similarity NPC242771
0.8077 Intermediate Similarity NPC164289
0.8077 Intermediate Similarity NPC100366
0.8077 Intermediate Similarity NPC311642
0.8028 Intermediate Similarity NPC100917
0.8028 Intermediate Similarity NPC474954
0.8028 Intermediate Similarity NPC180777
0.8028 Intermediate Similarity NPC469724
0.8028 Intermediate Similarity NPC103647
0.8028 Intermediate Similarity NPC2568
0.8028 Intermediate Similarity NPC260319
0.8028 Intermediate Similarity NPC31187
0.8028 Intermediate Similarity NPC281203
0.8025 Intermediate Similarity NPC33768
0.8025 Intermediate Similarity NPC134197
0.8025 Intermediate Similarity NPC252714
0.8 Intermediate Similarity NPC201655
0.8 Intermediate Similarity NPC294438
0.8 Intermediate Similarity NPC264317
0.8 Intermediate Similarity NPC471046
0.7975 Intermediate Similarity NPC471037
0.7973 Intermediate Similarity NPC133922
0.7949 Intermediate Similarity NPC48756
0.7949 Intermediate Similarity NPC280781
0.7941 Intermediate Similarity NPC306750
0.7922 Intermediate Similarity NPC201459
0.7922 Intermediate Similarity NPC245029
0.7922 Intermediate Similarity NPC52951
0.7922 Intermediate Similarity NPC31302
0.7922 Intermediate Similarity NPC192744
0.7917 Intermediate Similarity NPC295788
0.7917 Intermediate Similarity NPC178541
0.7901 Intermediate Similarity NPC472272
0.7901 Intermediate Similarity NPC80590
0.7901 Intermediate Similarity NPC2783
0.7901 Intermediate Similarity NPC70661
0.7901 Intermediate Similarity NPC302111
0.7895 Intermediate Similarity NPC171658
0.7867 Intermediate Similarity NPC159789
0.7857 Intermediate Similarity NPC230047
0.7857 Intermediate Similarity NPC19311
0.7848 Intermediate Similarity NPC148740
0.7848 Intermediate Similarity NPC170985
0.7848 Intermediate Similarity NPC102156
0.7838 Intermediate Similarity NPC474123
0.7826 Intermediate Similarity NPC114891
0.7821 Intermediate Similarity NPC470609
0.7808 Intermediate Similarity NPC91369
0.7805 Intermediate Similarity NPC269360
0.7805 Intermediate Similarity NPC264005
0.7792 Intermediate Similarity NPC471045
0.7792 Intermediate Similarity NPC26029
0.7792 Intermediate Similarity NPC31031
0.7792 Intermediate Similarity NPC243594
0.7792 Intermediate Similarity NPC63020
0.7792 Intermediate Similarity NPC472608
0.7778 Intermediate Similarity NPC283733
0.7778 Intermediate Similarity NPC470956
0.7763 Intermediate Similarity NPC476601
0.775 Intermediate Similarity NPC217559
0.775 Intermediate Similarity NPC292458
0.775 Intermediate Similarity NPC268578
0.775 Intermediate Similarity NPC472744
0.775 Intermediate Similarity NPC15821
0.7738 Intermediate Similarity NPC77756
0.7733 Intermediate Similarity NPC472944
0.7733 Intermediate Similarity NPC472945
0.7722 Intermediate Similarity NPC271572
0.7722 Intermediate Similarity NPC469745
0.7722 Intermediate Similarity NPC474484
0.7722 Intermediate Similarity NPC103754
0.7722 Intermediate Similarity NPC77311
0.7722 Intermediate Similarity NPC474870
0.7711 Intermediate Similarity NPC255176
0.7711 Intermediate Similarity NPC211162
0.7711 Intermediate Similarity NPC16377
0.7711 Intermediate Similarity NPC4309
0.7711 Intermediate Similarity NPC474719
0.7711 Intermediate Similarity NPC471900
0.7711 Intermediate Similarity NPC146937
0.7711 Intermediate Similarity NPC183374
0.7703 Intermediate Similarity NPC290058
0.7692 Intermediate Similarity NPC220379
0.7692 Intermediate Similarity NPC471475
0.7683 Intermediate Similarity NPC472505
0.7683 Intermediate Similarity NPC155011
0.7681 Intermediate Similarity NPC71460
0.7681 Intermediate Similarity NPC148174

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC477929 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9275 High Similarity NPD6113 Clinical (unspecified phase)
0.9014 High Similarity NPD6117 Approved
0.8889 High Similarity NPD6116 Phase 1
0.8841 High Similarity NPD4789 Approved
0.8806 High Similarity NPD4224 Phase 2
0.8767 High Similarity NPD6697 Approved
0.8767 High Similarity NPD6114 Approved
0.8767 High Similarity NPD6115 Approved
0.8767 High Similarity NPD6118 Approved
0.8714 High Similarity NPD4808 Clinical (unspecified phase)
0.8714 High Similarity NPD4809 Clinical (unspecified phase)
0.8714 High Similarity NPD6081 Approved
0.8657 High Similarity NPD3171 Clinical (unspecified phase)
0.8611 High Similarity NPD3702 Approved
0.8571 High Similarity NPD4244 Approved
0.8571 High Similarity NPD4245 Approved
0.8451 Intermediate Similarity NPD5777 Approved
0.8429 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.8429 Intermediate Similarity NPD3698 Phase 2
0.8429 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.8286 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.8286 Intermediate Similarity NPD5360 Phase 3
0.8 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7867 Intermediate Similarity NPD3703 Phase 2
0.7703 Intermediate Similarity NPD4758 Discontinued
0.7564 Intermediate Similarity NPD3671 Phase 1
0.7531 Intermediate Similarity NPD4788 Approved
0.7442 Intermediate Similarity NPD8034 Phase 2
0.7442 Intermediate Similarity NPD8035 Phase 2
0.7391 Intermediate Similarity NPD3198 Approved
0.7342 Intermediate Similarity NPD5364 Discontinued
0.7229 Intermediate Similarity NPD4786 Approved
0.72 Intermediate Similarity NPD4267 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD6399 Phase 3
0.7105 Intermediate Similarity NPD4787 Phase 1
0.7033 Intermediate Similarity NPD6084 Phase 2
0.7033 Intermediate Similarity NPD6083 Phase 2
0.6988 Remote Similarity NPD3667 Approved
0.6912 Remote Similarity NPD3729 Clinical (unspecified phase)
0.6897 Remote Similarity NPD5737 Approved
0.6897 Remote Similarity NPD6672 Approved
0.6897 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6882 Remote Similarity NPD8418 Phase 2
0.686 Remote Similarity NPD5330 Approved
0.686 Remote Similarity NPD7334 Approved
0.686 Remote Similarity NPD6409 Approved
0.686 Remote Similarity NPD7521 Approved
0.686 Remote Similarity NPD7146 Approved
0.686 Remote Similarity NPD6684 Approved
0.6842 Remote Similarity NPD6705 Phase 1
0.6824 Remote Similarity NPD3666 Approved
0.6824 Remote Similarity NPD3665 Phase 1
0.6824 Remote Similarity NPD3133 Approved
0.6818 Remote Similarity NPD5328 Approved
0.6747 Remote Similarity NPD6928 Phase 2
0.6707 Remote Similarity NPD3617 Approved
0.6705 Remote Similarity NPD6903 Approved
0.6667 Remote Similarity NPD6098 Approved
0.6667 Remote Similarity NPD615 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3618 Phase 1
0.6667 Remote Similarity NPD7515 Phase 2
0.6667 Remote Similarity NPD6079 Approved
0.663 Remote Similarity NPD5695 Phase 3
0.6629 Remote Similarity NPD4753 Phase 2
0.6596 Remote Similarity NPD7638 Approved
0.6596 Remote Similarity NPD5696 Approved
0.6588 Remote Similarity NPD4221 Approved
0.6588 Remote Similarity NPD4223 Phase 3
0.6552 Remote Similarity NPD5329 Approved
0.6538 Remote Similarity NPD3725 Approved
0.6538 Remote Similarity NPD3726 Approved
0.6531 Remote Similarity NPD6402 Approved
0.6531 Remote Similarity NPD6675 Approved
0.6531 Remote Similarity NPD7128 Approved
0.6531 Remote Similarity NPD5739 Approved
0.6526 Remote Similarity NPD7640 Approved
0.6526 Remote Similarity NPD7639 Approved
0.6522 Remote Similarity NPD7748 Approved
0.6477 Remote Similarity NPD5279 Phase 3
0.6471 Remote Similarity NPD4139 Approved
0.6471 Remote Similarity NPD4692 Approved
0.6462 Remote Similarity NPD634 Phase 3
0.6444 Remote Similarity NPD6904 Approved
0.6444 Remote Similarity NPD6673 Approved
0.6444 Remote Similarity NPD6080 Approved
0.6437 Remote Similarity NPD4197 Approved
0.6429 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6413 Remote Similarity NPD4202 Approved
0.64 Remote Similarity NPD6881 Approved
0.64 Remote Similarity NPD6899 Approved
0.64 Remote Similarity NPD7320 Approved
0.6392 Remote Similarity NPD7632 Discontinued
0.6377 Remote Similarity NPD3186 Phase 1
0.6364 Remote Similarity NPD375 Phase 2
0.6353 Remote Similarity NPD7525 Registered
0.6341 Remote Similarity NPD7339 Approved
0.6341 Remote Similarity NPD6942 Approved
0.6337 Remote Similarity NPD6373 Approved
0.6337 Remote Similarity NPD6372 Approved
0.6333 Remote Similarity NPD5208 Approved
0.6316 Remote Similarity NPD7909 Approved
0.6316 Remote Similarity NPD7902 Approved
0.631 Remote Similarity NPD4802 Phase 2
0.631 Remote Similarity NPD4238 Approved
0.631 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6304 Remote Similarity NPD5284 Approved
0.6304 Remote Similarity NPD5281 Approved
0.63 Remote Similarity NPD5701 Approved
0.63 Remote Similarity NPD5697 Approved
0.6292 Remote Similarity NPD4138 Approved
0.6292 Remote Similarity NPD4688 Approved
0.6292 Remote Similarity NPD4689 Approved
0.6292 Remote Similarity NPD5205 Approved
0.6292 Remote Similarity NPD4690 Approved
0.6292 Remote Similarity NPD4693 Phase 3
0.6277 Remote Similarity NPD4629 Approved
0.6277 Remote Similarity NPD5210 Approved
0.6277 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6275 Remote Similarity NPD7102 Approved
0.6275 Remote Similarity NPD7290 Approved
0.6275 Remote Similarity NPD6883 Approved
0.6269 Remote Similarity NPD2266 Phase 2
0.6264 Remote Similarity NPD7285 Clinical (unspecified phase)
0.625 Remote Similarity NPD3668 Phase 3
0.6238 Remote Similarity NPD6011 Approved
0.6214 Remote Similarity NPD6649 Approved
0.6214 Remote Similarity NPD6869 Approved
0.6214 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6214 Remote Similarity NPD6847 Approved
0.6214 Remote Similarity NPD6650 Approved
0.6214 Remote Similarity NPD6617 Approved
0.6214 Remote Similarity NPD8130 Phase 1
0.6211 Remote Similarity NPD4697 Phase 3
0.6211 Remote Similarity NPD5221 Approved
0.6211 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6211 Remote Similarity NPD5222 Approved
0.6207 Remote Similarity NPD4752 Clinical (unspecified phase)
0.62 Remote Similarity NPD6920 Discontinued
0.6176 Remote Similarity NPD6013 Approved
0.6176 Remote Similarity NPD6014 Approved
0.6176 Remote Similarity NPD6012 Approved
0.6154 Remote Similarity NPD8297 Approved
0.6154 Remote Similarity NPD6882 Approved
0.6146 Remote Similarity NPD5173 Approved
0.6146 Remote Similarity NPD4755 Approved
0.6132 Remote Similarity NPD6940 Discontinued
0.6129 Remote Similarity NPD6050 Approved
0.6129 Remote Similarity NPD5693 Phase 1
0.6111 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6111 Remote Similarity NPD5690 Phase 2
0.6111 Remote Similarity NPD4694 Approved
0.6111 Remote Similarity NPD5280 Approved
0.6095 Remote Similarity NPD8298 Phase 2
0.6095 Remote Similarity NPD8133 Approved
0.6078 Remote Similarity NPD6415 Discontinued
0.6071 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6024 Remote Similarity NPD6924 Approved
0.6024 Remote Similarity NPD6926 Approved
0.6022 Remote Similarity NPD5207 Approved
0.6022 Remote Similarity NPD5692 Phase 3
0.602 Remote Similarity NPD4700 Approved
0.602 Remote Similarity NPD5286 Approved
0.602 Remote Similarity NPD6404 Discontinued
0.602 Remote Similarity NPD5285 Approved
0.602 Remote Similarity NPD4696 Approved
0.6 Remote Similarity NPD7900 Approved
0.6 Remote Similarity NPD387 Clinical (unspecified phase)
0.6 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6 Remote Similarity NPD6001 Approved
0.5981 Remote Similarity NPD6868 Approved
0.598 Remote Similarity NPD6412 Phase 2
0.5976 Remote Similarity NPD4243 Approved
0.596 Remote Similarity NPD5223 Approved
0.5957 Remote Similarity NPD7637 Suspended
0.5957 Remote Similarity NPD5694 Approved
0.5957 Remote Similarity NPD6411 Approved
0.5955 Remote Similarity NPD5362 Discontinued
0.5952 Remote Similarity NPD2257 Approved
0.5943 Remote Similarity NPD4632 Approved
0.593 Remote Similarity NPD4776 Phase 2
0.593 Remote Similarity NPD4777 Suspended
0.5926 Remote Similarity NPD7115 Discovery
0.5914 Remote Similarity NPD6051 Approved
0.5909 Remote Similarity NPD5369 Approved
0.59 Remote Similarity NPD5226 Approved
0.59 Remote Similarity NPD4633 Approved
0.59 Remote Similarity NPD5225 Approved
0.59 Remote Similarity NPD5224 Approved
0.59 Remote Similarity NPD5211 Phase 2
0.5895 Remote Similarity NPD8171 Discontinued
0.5882 Remote Similarity NPD6933 Approved
0.5876 Remote Similarity NPD7614 Phase 1
0.5872 Remote Similarity NPD6335 Approved
0.5862 Remote Similarity NPD4195 Approved
0.5862 Remote Similarity NPD7645 Phase 2
0.5854 Remote Similarity NPD4747 Approved
0.5846 Remote Similarity NPD2270 Approved
0.5843 Remote Similarity NPD6435 Approved
0.5842 Remote Similarity NPD4754 Approved
0.5842 Remote Similarity NPD5174 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data